The drug safety ecosystem and PV have become increasingly complex and costly with annual PV budgets tripling in less than 5 years. Non-compliant reporting on PV can cost Pharma companies up to billions of dollars in fines and lost opportunity. Adverse drug events can be deadly if not properly managed.
During this event, our speakers will introduce the audience to Digital PV, an intelligent automation solution, which delivers end-to-end ICSR processes using a combination of RPA (Robotic Process Automation), AI (Artificial Intelligence) and ML (Machine Learning), in order to automate repetitive tasks thus freeing up employees to focus on higher-value work.
Our global Life Sciences experts, consisting of Vijay Rajagopalan - Cognizant, and Catherine Calarco - Automation Anywhere, will lead this insightful discussion with focus on how leading companies have implemented intelligent automation and the associated impact and return.